WallStSmart

National Health Investors Inc (NHI)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 1373% more annual revenue ($6.42B vs $435.78M). NHI leads profitability with a 38.3% profit margin vs 4.1%. NHI appears more attractively valued with a PEG of 4.76. NHI earns a higher WallStSmart Score of 52/100 (C-).

NHI

Buy

52

out of 100

Grade: C-

Growth: 4.0Profit: 8.0Value: 6.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.98

VTR

Hold

41

out of 100

Grade: D

Growth: 6.0Profit: 4.5Value: 2.0Quality: 4.0
Piotroski: 4/9Altman Z: 0.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NHIUndervalued (+34.5%)

Margin of Safety

+34.5%

Fair Value

$134.80

Current Price

$70.32

$64.48 discount

UndervaluedFair: $134.80Overvalued
VTRSignificantly Overvalued (-16.5%)

Margin of Safety

-16.5%

Fair Value

$76.72

Current Price

$89.99

$13.27 premium

UndervaluedFair: $76.72Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NHI3 strengths · Avg: 9.3/10
Profit MarginProfitability
38.3%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
61.3%10/10

Strong operational efficiency at 61.3%

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

VTR1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

Areas to Watch

NHI4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.762/10

Expensive relative to growth rate

Revenue GrowthGrowth
-2.6%2/10

Revenue declined 2.6%

EPS GrowthGrowth
-43.0%2/10

Earnings declined 43.0%

VTR4 concerns · Avg: 2.5/10
Return on EquityProfitability
1.8%3/10

ROE of 1.8% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

PEG RatioValuation
5.152/10

Expensive relative to growth rate

P/E RatioValuation
163.4x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : NHI

The strongest argument for NHI centers on Profit Margin, Operating Margin, Price/Book. Profitability is solid with margins at 38.3% and operating margin at 61.3%.

Bull Case : VTR

The strongest argument for VTR centers on Revenue Growth. Revenue growth of 21.7% demonstrates continued momentum.

Bear Case : NHI

The primary concerns for NHI are Piotroski F-Score, PEG Ratio, Revenue Growth.

Bear Case : VTR

The primary concerns for VTR are Return on Equity, Profit Margin, PEG Ratio. A P/E of 163.4x leaves little room for execution misses. Thin 4.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

NHI profiles as a declining stock while VTR is a growth play — different risk/reward profiles.

VTR carries more volatility with a beta of 0.72 — expect wider price swings.

VTR is growing revenue faster at 21.7% — sustainability is the question.

NHI generates stronger free cash flow (63M), providing more financial flexibility.

Bottom Line

NHI scores higher overall (52/100 vs 41/100), backed by strong 38.3% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

National Health Investors Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs.

Visit Website →

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?